| NAV | $11.57 | Daily Change | $0.03 | 0.26% |
| Market Price | $11.52 | Daily Change | -$0.07 | -0.60% |
The global telemedicine market increased over 6% from 2021 to 2022, exceeding $75bn. Forecasts suggest the market could reach over $200bn by 2027.1
In 2019, an estimated half of the global population lacked essential health care services.2 As more underserved markets gain broadband access, telemedicine offers vast opportunity to bridge the divide.
The pandemic increased adoption of digital health services, with many turning to telemedicine for the first time, accelerating the theme’s reach.
1Statista, Dec 2022
2World Economic Forum
| Inception Date | 07/29/20 |
| Total Expense Ratio | 0.68% |
| Net Assets | $133.62 million |
| NAV | $11.57 |
| Fact Sheet |
The Global X Telemedicine & Digital Health ETF (EDOC) seeks to invest in companies positioned to benefit from further advances in the field of telemedicine and digital health. This includes companies involved in Telemedicine, Health Care Analytics, Connected Health Care Devices, and Administrative Digitization.
The Global X Telemedicine & Digital Health ETF (EDOC) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Telemedicine & Digital Health Index.
| Ticker | EDOC |
| Bloomberg Index Ticker | SOLEDOC |
| CUSIP | 37954Y285 |
| ISIN | US37954Y2853 |
| Primary Exchange | Nasdaq |
| Shares Outstanding | 11,550,000 |
| Number of Holdings | 39 |
| 30-Day Median Bid-Ask Spread | 0.51% |
| 30-Day SEC Yield | 0.13% |
| Distribution Frequency | Semi-Annually |
| NAV | $11.57 | Daily Change | $0.03 | 0.26% |
| Market Price | $11.52 | Daily Change | -$0.07 | -0.60% |
|
As of recent (12/31/22)
As of recent (12/31/22)
|
Fund NAV | Market Price | Index |
|---|---|---|---|
| 1 Year | -29.43% | -29.99% | -29.07% |
| Since Inception | -10.36% | -10.67% | -9.85% |
| 1 Year | -18.91% | -19.20% | -18.84% |
| Since Inception | -9.53% | -9.80% | -9.17% |
| Year-to-Date | -29.43% | -29.99% | -29.07% |
| 1 Month | -4.50% | -5.08% | -4.46% |
| 3 Months | 3.18% | 2.48% | 3.77% |
| Since Inception | -23.28% | -23.94% | -22.24% |
| Year-to-Date | 0.60% | 0.69% | 0.28% |
| 1 Month | -6.00% | -6.65% | -6.31% |
| 3 Months | -3.92% | -4.43% | -4.20% |
| Since Inception | -22.82% | -23.42% | -22.02% |
Performance is shown on a total return basis (i.e., with gross income reinvested, where applicable). Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance, when observed, is unusual and investors should not expect such performance to be repeated.
| Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
|---|---|---|---|---|---|---|
| 6.23 | 241 HK | ALIBABA HEALTH | BRXVS60 | 0.78 | 10,565,100 | 8,290,892.14 |
| 5.91 | 6618 HK | JD HEALTH INTERN | BMW8R04 | 8.01 | 981,650 | 7,866,005.71 |
| 5.46 | MASI | MASIMO CORP | B1YWR63 | 174.42 | 41,668 | 7,267,732.56 |
| 5.29 | DOCS | DOXIMITY INC-CLASS A | BMD22Y4 | 32.91 | 213,663 | 7,031,649.33 |
| 4.70 | DXCM | DEXCOM INC | B0796X4 | 114.50 | 54,632 | 6,255,364.00 |
| 4.04 | IRTC | IRHYTHM TECHNOLOGIES INC | BYT4ST5 | 119.23 | 45,085 | 5,375,484.55 |
| 4.01 | A | AGILENT TECHNOLOGIES INC | 2520153 | 131.13 | 40,711 | 5,338,433.43 |
| 3.94 | LH | LABORATORY CP | 2586122 | 214.65 | 24,388 | 5,234,884.20 |
| 3.90 | RMD AU | RESMED INC-CDI | 6221667 | 21.27 | 243,862 | 5,185,868.83 |
| 3.85 | ILMN | ILLUMINA INC | 2613990 | 216.95 | 23,616 | 5,123,491.20 |
| 3.82 | TDOC | TELADOC HEALTH INC | BYQRFY1 | 24.23 | 209,628 | 5,079,286.44 |
| 3.65 | UNH | UNITEDHEALTH GROUP INC | 2917766 | 469.91 | 10,325 | 4,851,820.75 |
| 3.51 | SGFY | SIGNIFY HEALTH-A | BMD8TD0 | 28.90 | 161,701 | 4,673,158.90 |
| 3.31 | RCM | R1 RCM INC | BP2S437 | 13.75 | 320,466 | 4,406,407.50 |
| 3.18 | PACB | PACIFIC BIOSCIEN | B4N8MH9 | 9.24 | 457,383 | 4,226,218.92 |
| 3.15 | TNDM | TANDEM DIABETES CARE INC | BF3W461 | 41.73 | 100,507 | 4,194,157.11 |
| 3.04 | OMCL | OMNICELL INC | 2789523 | 56.02 | 72,266 | 4,048,341.32 |
| 2.90 | AMN | AMN HEALTHCARE | 2813552 | 82.70 | 46,690 | 3,861,263.00 |
| 2.65 | VCYT | VERACYTE INC | BFTWZY0 | 22.12 | 159,079 | 3,518,827.48 |
| 2.59 | PHR | PHREESIA INC | BKF9DQ8 | 30.99 | 111,192 | 3,445,840.08 |
| 2.37 | COP GR | COMPUGROUP MEDIC | BMY7CH1 | 51.10 | 61,624 | 3,148,745.01 |
| 2.35 | MDRX | VERADIGM INC | 2710039 | 12.89 | 242,811 | 3,129,833.79 |
| 2.20 | 1833 HK | PING AN HEALTHCA | BDRYVB3 | 2.69 | 1,086,300 | 2,919,975.29 |
| 1.69 | HIMS | HIMS & HERS HEALTH INC | BN46048 | 9.41 | 238,640 | 2,245,602.40 |
| 1.55 | NXGN | NEXTGEN HEALTHCARE INC | BF5L3D6 | 16.69 | 123,239 | 2,056,858.91 |
| 1.48 | TWST | TWIST BIOSCIENCE CORP | BGKG6G7 | 15.98 | 122,909 | 1,964,085.82 |
| 1.16 | DCGO | DOCGO INC | BKP4P23 | 8.73 | 176,329 | 1,539,352.17 |
| 1.11 | 4480 JP | MEDLEY INC | BK93ZN7 | 33.17 | 44,489 | 1,475,664.76 |
| 1.05 | SHCR | SHARECARE INC | BJL95B4 | 2.19 | 637,649 | 1,396,451.31 |
| 0.82 | LFST | LIFESTANCE HEALT | BN0TRB7 | 7.07 | 155,102 | 1,096,571.14 |
| 0.77 | AMWL | AMERICAN WELL -A | BN0SDK5 | 2.24 | 458,548 | 1,027,147.52 |
| 0.76 | GDRX | GOODRX HOLDIN-A | BMTVQT8 | 6.42 | 156,804 | 1,006,681.68 |
| 0.67 | CPSI | COMPUTER PROGRAM | 2872122 | 28.27 | 31,606 | 893,501.62 |
| 0.56 | DH | DEFINITIVE HEALT | BMGSDK2 | 10.61 | 70,312 | 746,010.32 |
| 0.52 | BNGO | BIONANO GENOMICS INC | BFY8K60 | 1.09 | 639,979 | 697,577.11 |
| 0.50 | NVTA | INVITAE CORP | BVVCNT1 | 1.28 | 518,557 | 663,752.96 |
| 0.49 | SENS | SENSEONICS HOLDINGS INC | BYQNYR5 | 0.72 | 913,377 | 654,160.61 |
| 0.39 | OPRX | OPTIMIZERX CORP | BF5MM09 | 14.03 | 37,182 | 521,663.46 |
| 0.25 | HLTH | CUE HEALTH INC | BM9J045 | 1.80 | 186,535 | 335,763.00 |
| 0.18 | CASH | 1.00 | 244,950 | 244,950.26 | ||
| 0.00 | EURO | 1.09 | 10 | 10.56 | ||
| 0.00 | HONG KONG DOLLAR | 0.13 | 4 | 0.51 |
| Sector | Weight (%) | |
|---|---|---|
| Health Care | 93.1 | |
| Consumer Discretionary | 5.1 | |
| Financials | 1.2 | |
| Information Technology | 0.6 |
Source: AltaVista Research, LLC
| Country | Weight (%) | |
|---|---|---|
| United States | 84.3 | |
| China | 6.9 | |
| Hong Kong | 5.6 | |
| Germany | 2.2 | |
| Japan | 1.0 |
Source: AltaVista Research, LLC
| Return on Equity | -1.70% | |
| Weighted Avg. Market Cap | 28,296 M | |
| 2022 | 2023 | |
| Price-to-earnings | -6.40 | -170.97 |
| Price-to-book value | 2.85 | 2.93 |
Source: AltaVista Research, LLC
| Versus | Beta |
|---|---|
| S&P 500 | 0.87 |
| MSCI EAFE | 0.84 |
| MSCI Emg. Mkts | 0.77 |
| Standard Deviation | 22.40% |
Source: AltaVista Research, LLC
Investing involves risk, including the possible loss of principal. The investable universe of companies in which EDOC may invest may be limited. The Fund invests in securities of companies engaged in the Health Care and Information Technology sectors. These sectors can be affected by government regulations, rapid product obsolescence, intense industry competition and loss or impairment of patents or intellectual property rights. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. EDOC is non-diversified.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.
Since the Fund’s shares did not trade in the secondary market until several days after the Fund’s inception, for the period from inception to the first day of secondary market trading in Shares, the NAV of the Fund is used to calculate market returns.
Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.
Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Solactive AG, nor does Solactive AG make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Solactive AG.